Hospital begins monoclonal antibody treatment

Hospital begins monoclonal antibody treatment
Updated:
Updated:
Drug is said to bring down hospitalisation by 70%
Share Article
Drug is said to bring down hospitalisation by 70%
Kauvery Hospital in Chennai has treated a mildly symptomatic but high-risk COVID-19 patient with the monoclonal antibody cocktail that has been approved for emergency use in India. A statement issued by the hospital claimed that this was the first time the treatment had been used by a hospital in Tamil Nadu.
The individual was a cancer patient, who was recently diagnosed with early onset of renal failure, and hence was at higher risk of developing severe complications due to COVID-19.

Related Keywords

India ,Chennai ,Tamil Nadu ,Aravindan Selvaraj ,Anita Ramesh ,Central Drugs Standards Control Organisation Of India ,Kauvery Hospital ,Switzerland Based Roche ,Central Drugs Standards Control Organisation ,Emergency Use Authorisation , ,இந்தியா ,சென்னை ,தமிழ் நாடு ,அரவிந்தன் செல்வராஜ் ,அனிதா ரமேஷ் ,கௌஊவேறி மருத்துவமனை ,சுவிட்சர்லாந்து அடிப்படையிலானது ரோச் ,மைய மருந்துகள் தரநிலைகள் கட்டுப்பாடு ஆர்கநைஸேஶந் ,